Home » Gene » Page 4
Tag:

Gene

Technology

Fetal Brain Development Links to Autism, Depression, and Neurodegenerative Diseases

by Rachel Kim – Technology Editor
written by Rachel Kim – Technology Editor

This article discusses a study by the Hospital del Mar Research Institute and Yale university, published in Nature Communications, which suggests that the origins of several neuropsychiatric and neurodegenerative diseases, including autism, bipolar disorder, depression, alzheimer’s, and Parkinson’s, can be traced back to very early stages of fetal brain development.

The research focused on the role of genes linked to these diseases in fetal brain stem cells.By simulating the effects of alterations in nearly 3,000 genes associated with these conditions, the study found that many of these genes are already active during the initial phases of fetal development when stem cells are forming the brain.

The researchers combined data from human and mouse brains, as well as in vitro cellular models, to overcome the difficulty of studying this early developmental period. They discovered that genes implicated in mental illnesses often act during the early stages of fetal brain formation, and their alterations can lead to developmental issues and later-onset mental disorders.

The study simulated regulatory networks for different cell types involved in brain development to understand how gene activation or deactivation affected progenitor cells.This revealed the significance of specific genes in the development of various conditions, ranging from microcephaly and hydrocephaly to autism, depression, bipolar disorder, anorexia, schizophrenia, Alzheimer’s, and Parkinson’s.Crucially, the research identified that genes involved in the earliest phases of brain development, when neural stem cells are functional, are implicated in all these pathologies. The study pinpoints specific temporal windows and cell types where these genes are most relevant, offering insights into when and where interventions might be most effective.this understanding of the origin of these diseases and the role of specific genes can pave the way for developing targeted therapies, including gene therapy and personalized treatments, to address these conditions.

0 comments
0 FacebookTwitterPinterestEmail
Health

New research identifies critical gene for treatment

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

ALS Breakthrough Pinpoints Common Weakness

New Research Identifies UNC13A Gene as Key Target for Treatment

Scientists have uncovered a unifying molecular mechanism in Amyotrophic Lateral Sclerosis (ALS), a devastating neurodegenerative disease. This discovery centers on the gene UNC13A, crucial for nerve cell communication, offering a promising new avenue for developing effective therapies.

Unraveling ALS Complexity

For years, the genetic diversity of ALS has complicated the search for a single effective treatment. Different genetic mutations, such as those affecting TDP-43, FUS, MATR3, and hnRNPA1, lead to varied pathological pathways. This heterogeneity makes it challenging to find a common therapeutic target.

“Scientists still don’t fully understand the process behind the loss of motor neurons in ALS. ALS is known for its genetic heterogeneity – meaning that there are numerous possible combinations of genes and factors that could lead to ALS. This makes it difficult to develop a singular treatment that works for everyone.”

—Yasuaki Watanabe, Assistant Professor, Tohoku University

A research team from Tohoku University and Keio University aimed to bridge this gap. They generated neural cell lines where key ALS-related RNA-binding proteins were depleted. Consistently, they observed a significant reduction in UNC13A expression across all tested cell lines.

Two Paths to UNC13A Deficiency

The study identified two distinct molecular routes leading to lower UNC13A levels. One pathway involves the insertion of a cryptic exon into the UNC13A transcript, destabilizing the messenger RNA. The second, novel finding revealed that the loss of FUS, MATR3, or hnRNPA1 triggers the overexpression of REST, a known transcriptional repressor.

REST actively suppresses UNC13A gene transcription. This increased REST activity may be the underlying cause of the motor neuron damage seen in ALS patients. The researchers validated these findings by examining motor neurons from ALS patient iPS cells and post-mortem spinal cord tissues, confirming elevated REST levels.

UNC13A: A Central Hub for Therapy

This convergence of diverse ALS-causing mutations on UNC13A deficiency provides critical insights into the disease. It highlights UNC13A as a central player in ALS pathology. Strategies aimed at preserving UNC13A expression or modulating REST activity could offer broad-spectrum therapeutic benefits.

“This study provides a valuable framework for developing broad-spectrum treatments that target shared molecular vulnerabilities in ALS,” stated **Keiko Nakayama**, Professor at Tohoku University.

With an estimated 30,000 people living with ALS in the United States alone, the potential to slow or halt the progression of muscle wasting and loss of function in a wider patient population would represent a monumental advancement in patient care (ALS Association).

0 comments
0 FacebookTwitterPinterestEmail
Health

Gene-Edited Mosquitoes Drive Near-Zero Malaria Transmission

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Here’s a breakdown of the provided text, focusing on the key findings and implications:

Core Finding:

The study demonstrates that a specific genetic modification in the mosquito Anopheles stephensi, specifically a single amino acid change in the FREP1 gene (FREP1Q224), can make the mosquitoes largely resistant to malaria parasites. This resistance is achieved by biasing the inheritance of this protective allele through a “linked allelic drive” mechanism.

Key Results:

Malaria Refractoriness:
 The FREP1Q224 allele considerably reduced the number of Plasmodium falciparum (human malaria) sporozoites in mosquito salivary glands, effectively preventing transmission.
It also reduced oocyst development in the midgut.
 this refractoriness was observed even against a different rodent malaria parasite (Plasmodium berghei), suggesting broad-spectrum activity.
The resistance was homozygous-dependent, meaning both copies of the FREP1 gene needed to have the protective allele for full effect.Heterozygotes showed no significant protection.

Efficient Allelic Drive:
A gene-editing system (guide RNA + Cas9) was used to convert the natural allele (FREP1L224) to the protective allele (FREP1Q224) in mosquitoes.
 This conversion process was highly efficient, achieving protective allele frequencies of up to 93% in the second generation.
In population cages, the protective allele rapidly increased in frequency, reaching over 90% within 10 generations, starting from a 25% initial frequency.
 The drive mechanism was so effective that it outcompeted other alleles, even those on congenic chromosomes, indicating it wasn’t due to a general fitness advantage of the protective allele itself.

Mechanism of Spread:
 Bayesian modeling suggested that the rapid spread of the protective allele was driven by a combination of:
High allelic conversion rates.
 Low rates of non-functional resistance alleles.
“Lethal sterile mosaicism,” where mosquitoes with onyl one copy of the protective allele (heterozygotes) and exposed to the gene-editing machinery experienced severe fitness penalties due to mutations in their own genes.

Population-Level Impact:
Mosquito populations that had undergone the allelic drive showed near-complete suppression of Plasmodium falciparum oocysts,confirming they had become largely transmission-refractory.

Conclusions and Implications:

Realistic Malaria Control strategy: The study presents a promising and realistic strategy for malaria control by genetically modifying mosquitoes to be refractory to the parasite.
Population-Kind Approach: The protective allele preserves normal mosquito biology and doesn’t impose significant fitness costs on the mosquitoes themselves, making it a perhaps “population-friendly” approach.
 Complementary to Existing Methods: This genetic approach can complement existing malaria control tools like bed nets, indoor spraying, and drugs, which are increasingly threatened by resistance.
Broader Applications: The same genetic framework could be used to reintroduce insecticide sensitivity or deploy other beneficial host traits in mosquitoes.
 Pre-Deployment Considerations: The authors emphasize the critical need for rigorous ecological, ethical, and governance frameworks, and also confinement strategies, before any real-world deployment.

In essence, the study successfully engineered mosquitoes to be malaria-resistant and demonstrated a method to rapidly spread this resistance through a mosquito population using gene drive technology.

0 comments
0 FacebookTwitterPinterestEmail
Health

AI Reveals Six New Alzheimer’s Risk Genes Using Machine Learning

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Here’s a breakdown of the provided text, focusing on the key findings and their implications:

Key Findings Regarding AD Status Prediction:

Comparable Accuracy: All machine learning (ML) models predicted Alzheimer’s Disease (AD) status with similar accuracy.
 Model Correlations:
Gradient Boosting Machine (GBM) and Neural Networks (NN) were strongly correlated.
 GBM and Multi-Dimensional Reduction (MDR) with 1-day data were also strongly correlated. Polygenic Risk Score (PRS) was weakly correlated with NNs but strongly linked to GBMs.
 Predicting Differentiating Cases: GBM and PRS were better at identifying cases that were distinct from controls.
Reproducibility: Predictions were validated through random data splits, indicating high reproducibility.
 Sex Representation:
Females were overrepresented among predicted cases, aligning with the majority female dataset.
 GBM was an exception, showing similar proportions of males and females in both cases and controls.
Model Stability: predictions remained consistent across different cohorts and repeated random splits, suggesting robustness and lack of overfitting.

Comparison with Genome-Wide Association Studies (GWAS):

Overlap: Out of 130 previously reported AD-associated genes (86 loci),ML algorithms identified 19.
APOE Identification: All ML models identified the APOE gene. Two models identified seven loci.
 Impact of APOE Exclusion: Removing the APOE region from the training data led to the identification of more known AD risk genes, but with reduced accuracy.
Training Data replication: When using only the current data, ML models identified every SNP detected by GWAS in the training set.
 ML-Identified SNP Location & Function:
High-priority SNPs identified by ML were more concentrated in microglial and astrocytic regions.
 These SNPs were involved in AD-related pathways, including:
Regulation of beta-amyloid protein.
 Changes in protein concentrations like Ly6h (linked to neurotransmission and AD severity). glycosylation abnormalities related to AD tau protein processing.
 SNP Importance Ranking Differences: The methods ML models use to rank SNP importance (e.g., SHAP values, permutation p-values, network weights) differ from conventional GWAS meaning, highlighting fundamental differences in feature selection.

Importance of the Study:

ML Efficacy: The study demonstrates that ML can predict AD-linked genetic variants as effectively as traditional genome-wide methods, especially with large datasets. GWAS Heterogeneity: The moderate accuracy of GWAS meta-analyses might be due to the heterogeneity of included studies.More homogeneous samples tend to yield higher odds ratios.
Context-Specific Effects: Some SNPs identified by ML might only show effects in specific cohorts or conditions, which might not be detectable in large, heterogeneous external datasets. This explains why not all ML-identified SNPs could be replicated externally.
 Novel Findings: Despite replication challenges, the novel SNPs identified by ML affected biologically plausible pathways. Further research is needed to understand how to best identify vital SNPs across different methods.

conclusions:

ML’s Predictive Power: ML methods can achieve predictive performance comparable to classical genetic epidemiology approaches.
 Finding of New Loci: ML can identify new AD-associated loci that traditional GWAS might miss.
reproducibility and Bias Minimization: The study’s reproducible approach helps minimize bias.
 Promise and Limitations: The work highlights the potential of ML in AD genetics but also emphasizes the need for careful interpretation, replication, and methodological refinement.
* Future Directions: This study paves the way for developing and validating ML models to complement conventional methods in AD genetic research.

0 comments
0 FacebookTwitterPinterestEmail
Health

Everyday diet ingredients like caffeine can affect bacterial antibiotic resistance

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Daily Habits Undermine Antibiotic Power

Common Foods, Drinks Can Fuel Bacterial Defense

Your daily coffee or a sip of soda might be inadvertently aiding bacteria in their fight against antibiotics, new research suggests. Scientists have uncovered how everyday dietary components can alter bacterial behavior, diminishing the effectiveness of vital medications.

Dietary Components Alter Bacterial Defenses

A team at the Universities of Tübingen and Würzburg, under the direction of Professor **Ana Rita Brochado**, identified that substances like caffeine can trigger complex internal processes within bacteria. These reactions enable bacteria, such as *Escherichia coli* (E. coli), to modify their cellular machinery, impacting how well antibiotics work.

The researchers systematically tested 94 different compounds, including medications and food ingredients, on E. coli. Their focus was on how these substances affect gene regulators and transport proteins. These proteins act as gatekeepers, controlling what enters and exits the bacterial cell, a critical factor for survival.

‘Antagonistic Interaction’ Weakens Drug Efficacy

“Our data show that several substances can subtly but systematically influence gene regulation in bacteria.”

—Christoph Binsfeld, PhD student and lead author

The study reveals that even substances without direct antibacterial effects can influence these transport proteins. For instance, caffeine initiates a chain reaction in E. coli, ultimately reducing the cell’s intake of antibiotics like ciprofloxacin. This creates an “antagonistic interaction,” where caffeine effectively blunts the antibiotic’s power.

Interestingly, this weakening effect was not observed in *Salmonella enterica*, a related bacterium. This highlights that even closely related species can respond differently to the same environmental factors, potentially due to variations in their transport systems.

Broader Implications for Public Health

This fundamental research sheds light on a subtle form of antibiotic resistance. It’s not caused by genetic mutations but rather by environmental adaptation and regulatory changes within the bacteria. Understanding these interactions could revolutionize treatment strategies, influencing not only medication timing and dosage but also considering the impact of co-administered food or supplements.

The World Health Organization estimates that antibiotic resistance could cause 10 million deaths annually by 2050 if no action is taken, underscoring the urgency of such research. This discovery emphasizes the need to consider the broader environmental context when combating bacterial infections.

The findings were published in the journal *PLOS Biology*. The research provides crucial insights into how bacteria adapt to their surroundings, offering new avenues for developing more effective antimicrobial therapies by accounting for everyday dietary influences.

0 comments
0 FacebookTwitterPinterestEmail
Health

New approach doubles chemotherapy effectiveness by targeting cancer cell memory

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Scientists Disrupt Cancer’s Defense Mechanism, Boosting Chemo Efficacy

Novel Approach Targets Cellular Adaptability, Not Just Tumors

A groundbreaking strategy from Northwestern University engineers has demonstrated the potential to significantly enhance chemotherapy’s power by preventing cancer cells from adapting and resisting treatment, a key factor in treatment failure.

Unlocking Chemo’s Full Potential

Researchers have discovered a way to neutralize cancer’s remarkable ability to evolve and withstand therapies. This new method focuses on the internal scaffolding of cancer cells, known as chromatin, which governs gene expression and cellular responses to stress. By subtly altering chromatin’s physical structure, scientists believe they can disarm cancer’s adaptive superpowers, making existing chemotherapy drugs far more effective.

This innovative approach achieved near-complete eradication of cancer in laboratory cell cultures. In animal trials involving human ovarian cancer models, the combination therapy dramatically improved the outcomes compared to chemotherapy alone.

“Cancer cells are great adapters. They can adapt to almost anything that’s thrown at them… We did not set out to directly kill cancer cells. We wanted to take away their superpower—removing their inherent abilities to adapt, to change and to evade.”

—Vadim Backman, Lead Study Author and Professor at Northwestern University

The findings, published in the Proceedings of the National Academy of Sciences, suggest that rather than developing new, potent drugs, the focus can shift to optimizing the delivery and efficacy of current treatments by inhibiting cancer’s resilience. This could lead to less toxic treatment regimens and improved patient quality of life.

Chromatin: The Key to Cancer’s Tenacity

Cancer’s persistent survival, even when faced with aggressive treatments, has long puzzled scientists. While genetic mutations play a role, they don’t fully explain the rapid adaptive responses observed. Researchers led by **Vadim Backman** identified the intricate organization of DNA and proteins within the cell nucleus, known as chromatin, as the critical factor. This complex structure not only controls gene activity but also acts as a cellular memory system, enabling cells to adapt to changing environments and stresses.

When this chromatin architecture becomes disordered, cancer cells gain increased “plasticity,” allowing them to quickly develop resistance to therapies like chemotherapy. The precise 3D arrangement of chromatin stores “transcriptional memory,” guiding cellular function and adaptation.

Reprogramming Cell Memory to Enhance Treatment

The Northwestern team developed a computational model to analyze how chromatin packing influences cancer cell survival. Their research pinpointed celecoxib, an existing anti-inflammatory medication, as a compound capable of modulating chromatin structure and reducing cellular plasticity. By combining celecoxib with standard chemotherapy agents, the researchers observed a significant increase in cancer cell death.

In preclinical trials, the combination of paclitaxel (a common chemotherapy) with celecoxib in mice with ovarian cancer significantly slowed tumor growth compared to paclitaxel alone. “It doubled the efficacy,” **Backman** stated, highlighting the substantial benefit of this combined approach.

The ability to make chemotherapy more effective could also allow for lower, more tolerable doses, potentially alleviating the severe side effects that often lead patients to discontinue treatment. For instance, in 2023, the American Cancer Society reported that over 1.9 million new cancer cases were diagnosed in the U.S. alone, underscoring the immense need for more effective and less burdensome treatments (American Cancer Society).

Future Applications Beyond Cancer

While initially focused on cancer, **Backman** believes that modulating chromatin conformation could offer therapeutic benefits for a range of complex diseases, including neurodegenerative conditions and heart disease. Many debilitating illnesses may stem from cells losing their correct functional “memories,” leading to loss of function or disease development. Restoring these cellular memories through chromatin reprogramming could offer a pathway to recovery.

“In many diseases, cells forget what they should be doing,” **Backman** explained. “Many impactful diseases of the 21st century are, to a large extent, related to cell memory.” He likens the computational processes within each cell’s chromatin to an early computer, emphasizing its capacity for storing and potentially altering cellular memory. This discovery could unlock a new era of “source code” manipulation for treating a variety of human ailments.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts
@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com